Carson Seana's Form 4/A amendment
AmendedBausch Health Companies Inc. (BHC) · filed Mar 7, 2023
- Accession no.
- 0001127602-23-009310
- Filed
- Mar 7, 2023
- Trade date
- Mar 3-6, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Mar 6, 2023
This filing lists 2 non-derivative transactions. It carries over 7 transactions from the original filing that it did not restate. Open-market sales total $11.8K. It was filed 4 days after the trade.
This amendment restates part of 0001127602-23-009099 (filed Mar 6, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carson SeanaCIK 0001923756 | Officer (EVP, General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 | Common Shares, No Par Value | SSaleDisposed | −780 | $9.34 | −$7,285.2 | 443,730 | Direct | |
| Mar 6, 2023 | Common Shares, No Par Value | SSaleDisposed | −495 | $9.17 | −$4,539.15 | 443,235 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001127602-23-009099 (filed Mar 6, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Common Shares, No Par Value | FTax withholdingDisposed | −5,994 | $9.25 | −$55,444.5 | 353,191 | Direct | |
| Mar 2, 2023 | Common Shares, No Par Value | AGrant or awardAcquired | +95,119 | $0.00 | $0 | 448,310 | Direct | |
| Mar 3, 2023 | Common Shares, No Par Value | FTax withholdingDisposed | −765 | $9.16 | −$7,007.4 | 447,545 | Direct | |
| Mar 3, 2023 | Common Shares, No Par Value | FTax withholdingDisposed | −511 | $9.16 | −$4,680.76 | 447,034 | Direct | |
| Mar 3, 2023 | Common Shares, No Par Value | FTax withholdingDisposed | −1,637 | $9.16 | −$14,994.92 | 445,397 | Direct | |
| Mar 3, 2023 | Common Shares, No Par Value | FTax withholdingDisposed | −887 | $9.16 | −$8,124.92 | 444,510 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Common Shares, No Par Value | AGrant or awardAcquired | +82,117 | $0.00 | $0 | 82,117 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.
- F2
This Form 4/A is being filed to correct the transaction code originally used to report this transaction on a Form 4 filed by the Reporting Person on 03/06/23. Due to an inadvertent administrative error, this transaction was originally incorrectly reported using code "F" instead of transaction code "S".